Introduction {#s1}
============

The past decade has witnessed a remarkable global surge in the incidence and severity of *Clostridium difficile* infection [@pmed.1001268-Kelly1]--[@pmed.1001268-Pepin1]. This pathogen has long been among the most burdensome hospital-acquired infections, but has now become a leading contributor to infectious disease morbidity and mortality in developed countries [@pmed.1001268-Kwong1]. The majority of *C. difficile* infections are acquired in hospital, and many of these are potentially preventable through strategies aimed at minimizing transmission between patients or decreasing patient susceptibility, primarily by reducing inappropriate antibiotic use [@pmed.1001268-Dubberke1].

Mandating public reporting of quality care metrics has been one vehicle used by health care payers to incentivize improvements in hospital care at a system level. Several theories have been put forth for how public reporting might improve patient outcomes: public reporting could encourage patients and their agents to select higher performing institutions (selection pathway), it could allow hospitals to identify areas of poor performance to target for improvement (change pathway), or it could motivate institutions to avoid the shame of a bad performance report and seek the pride of a good report (reputation pathway) [@pmed.1001268-Fung1],[@pmed.1001268-Hibbard1]. Most evidence, including a recent randomized trial of public reporting of cardiac quality indicators, suggests that the potential benefit is largely in stimulating quality improvement efforts [@pmed.1001268-Tu1]. However, the benefits and hazards of public reporting systems may vary depending on the specific clinical context (identification of appropriate measurements and responsible providers, and the need for risk adjustment) [@pmed.1001268-Fung1],[@pmed.1001268-Marshall1],[@pmed.1001268-Schauffler1], and public reporting is particularly understudied in the domain of hospital-acquired infections [@pmed.1001268-McKibben1].

In Ontario, Canada, the Ontario Ministry of Health and Long-Term Care (MOHLTC) selected *C. difficile* rates as the first among a slate of hospital patient safety indicators to be subject to mandatory monthly public reporting starting September 1, 2008 [@pmed.1001268-Ontario1]. Hospitals were obligated to collect their own data on hospital-acquired *C. difficile* infections, and report the data monthly to the MOHLTC for posting on a publicly accessible website. No additional hospital-level incentives or disincentives were initially implemented, but there was acknowledgment that hospital global budgets and hospital executive compensation could eventually be linked to hospital performance [@pmed.1001268-1].

The objective of our investigation was to utilize population-based health care data in Ontario, Canada, as an independent means to rigorously evaluate the impact of a public reporting system on province-wide, hospital-specific rates of this burdensome pathogen.

Methods {#s2}
=======

Ethics Statement {#s2a}
----------------

The study was approved by the research ethics board of Sunnybrook Health Sciences Centre.

General Study Design {#s2b}
--------------------

We conducted a retrospective, longitudinal population-based cohort study of all patients (\>1 y old) admitted to acute care hospitals in Ontario between April 1, 2002, and March 31, 2010. Poisson regression analysis was used to develop a high-fidelity predictive model of hospital rates of *C. difficile* infection prior to public reporting, to allow an assessment of the change in provincial hospital-specific rates of *C. difficile* infection following the introduction of mandatory public reporting (introduced September 2008).

Data Sources {#s2c}
------------

The cohort was derived from a linkage of well-validated, province-wide health care administrative databases housed at the Institute for Clinical Evaluative Sciences [@pmed.1001268-National1],[@pmed.1001268-Levy1]. The Registered Persons Database contains demographic data for all of Ontario\'s 12.2 million residents; the Ontario Health Insurance Plan database includes physician billing claims for all visits and procedures performed within Ontario\'s universal single-payer health care system; the Canadian Institute for Health Information Discharge Abstract Database details all hospitalization events; the Ontario Drug Benefit database contains comprehensive and accurate (\>99% concordant with chart review) outpatient drug information for Ontario\'s 1.2 million elderly residents [@pmed.1001268-Levy1].

*C. difficile* rates from health care administrative data were validated against rates reported by individual institutions via the mandatory public reporting system. Given that these reporting data are only available (by definition) from the period after the program was initiated, and given that they are aggregated at the hospital level (without any risk adjustment), they cannot be directly used to evaluate the impact of the program. Hospitals reported all cases of *C. difficile* diagnosed at their institution, using a standardized case definition, and were required to classify the origin of cases as (i) nosocomial acquisition from their institution, (ii) nosocomial acquisition from another institution, or (iii) community acquisition or unknown/indeterminate source. Only those cases deemed by the institution to have been acquired in their own hospital are incorporated into the numerator of monthly publicly reported rates. However, for this study we had access to overall *C. difficile* rates, including cases assigned to any of the three categories.

Patient Selection Criteria {#s2d}
--------------------------

We identified all patients admitted to an acute care hospital in Ontario between April 1, 2002, and March 31, 2010. We excluded infants as well as patients admitted to psychiatry, rehabilitation, and complex continuing care institutions, given low expected event rates, and the fact that admissions to these non-acute-care centers are recorded in separate, less well validated databases. The use of broad inclusion criteria was intended to generate population-based data, and avoid the selection bias that is inherent in clinical surveillance networks. In total, data from 180 acute care hospitals contributed to the analysis during the 8-y study period, including 165 which contributed data to the public reporting period (September 1, 2008, to March 31, 2010). Individual hospitals were included even if they were in existence for only part of the pre-intervention and/or post-intervention period(s), because even with hospital openings, closures, and mergers during the 9-y study period, the net population at risk was considered to be all Ontario patients admitted to acute care hospital beds.

Primary Predictor {#s2e}
-----------------

The primary predictor in this study was the date of initiation of mandatory public reporting of hospital *C. difficile* rates, which was implemented by the MOHLTC on September 1, 2008.

Outcome Definition {#s2f}
------------------

The primary outcome was the hospital- and age-specific monthly rates of *C. difficile* disease per 10,000 hospital patient-days. *C. difficile* disease is captured in the hospital database, through a single *International Classification of Diseases* (ICD) code (ICD-10 code A047). Two prior validation studies in the United States have indicated that ICD codes are sensitive (71%--88%) and specific (\>99%) for the diagnosis of *C. difficile* infection [@pmed.1001268-Dubberke2],[@pmed.1001268-Scheurer1]. It is less clear whether administrative databases can accurately distinguish the source of *C. difficile* acquisition, and so we included all cases rather than just those that were labelled as post-admission diagnoses [@pmed.1001268-Dubberke3].

Validation of *C. difficile* Rates in the Administrative Datasets {#s2g}
-----------------------------------------------------------------

For additional indirect validation of ICD-10 codes in the local context, data from September 1, 2008, to March 31, 2010 (the period of public reporting), were used to compare hospital-level *C. difficile* counts in the administrative data to publicly reported counts. Pearson correlation coefficients (weighted for hospital bed-days) were calculated for overall *C. difficile* cases and nosocomial *C. difficile* cases across the institutions subject to public reporting.

Risk Strata {#s2h}
-----------

Hospitalized patients were grouped into monthly, age group, and hospital-specific strata. Hospitalized patients were separated into nine age strata: 1--18, 19--30, 31--40, 41--50, 51--60, 61--70, 71--80, 81--90, and \>90 y old. In total there were 124,740 potential strata in the pre-intervention period (77 mo×nine age groups×180 institutions), and 30,780 potential strata in the post-intervention period (19 mo×nine age groups×180 institutions). The actual number of strata was slightly lower (133,418), given that not all age strata were represented in all hospital-months, and some hospitals were not in existence for the entire study duration.

Statistical Analysis {#s2i}
--------------------

### Primary analysis {#s2i1}

We first computed *C. difficile* rates by age group, month, and hospital strata prior to September 1, 2008, to visually inspect temporal trends, overall and by hospital. The numerator was the number of *C. difficile* cases in each stratum; the denominator was the at-risk hospitalized population in each stratum (10,000 patient-days). In the primary analysis, we examined whether the introduction of public reporting of *C. difficile* rates in September 2008 was associated with a significant decline in hospital-specific *C. difficile* rates.

To model the temporal patterns of *C. difficile* infections, we used generalized estimating equations for clustered count data to account for correlations among outcomes within hospitals over time, using an auto-regressive correlation structure with a period of 3 mo [@pmed.1001268-Zeger1]. The unit of analysis was the hospital, month, and age group stratum. The dependent variable was the number of *C. difficile* infections in each stratum; the offset parameter was the number of patient-days in each stratum. All models included age group, pre-reporting calendar month (to account for seasonal trends), hospital facility type (acute teaching, large community, or small community), concurrent and 1- to 12-mo lagged provincial monthly rates of prescriptions of antimicrobials, and indicator variables for each post-reporting month, coded as the difference between the specific post-reporting month and the corresponding pre-reporting calendar month. The exponentiated post-month regression coefficients thus represent the relative difference between the observed post-month and the predicted post-month based on the pre-reporting trends. We planned to model longitudinal trend with both linear and non-linear functions. Model fit was assessed through graphical inspection of observed and predicted rates over the pre-intervention period, as well as through deviance and Pearson chi-square statistics.

We used 6.5 y of data to model pre-reporting trends, and projected these trends to the post-reporting period after September 1, 2008, to obtain predicted rates in the absence of reporting. The predicted cases and 95% confidence intervals for a calendar month after public reporting were computed as the observed number of cases for that month divided by the corresponding relative rates from the model, as in previous work [@pmed.1001268-Schull1]. The overall relative difference in infection rates in the calendar year 2009 was obtained as the exponentiated weighted average of the regression coefficients corresponding to that period, weighting by log person-days. Averted cases were computed as the difference between predicted and observed cases in post-reporting months. The decrease in hospital *C. difficile* rates was computed for the overall population, as well as for hospital facility subtypes. In a sensitivity analysis, to test the robustness of our results and to ensure that findings were not being driven by coding practices in a few large institutions, we excluded hospitals with discordant rates of *C. difficile* in the public reporting and administrative datasets.

### Tracer analyses {#s2i2}

To test the specificity of our findings, we examined tracer outcomes that should not be impacted by *C. difficile* public reporting. First, we inspected hospital admissions for other bacterial gastrointestinal pathogens. These pathogens (*Salmonella*, *Shigella*, *Campylobacter*, *Listeria*, and *Yersinia*, among others) are almost universally community-acquired, to the extent that microbiology laboratory guidelines recommend against testing for these pathogens when infections arise more than 72 h post-admission [@pmed.1001268-Gilligan1]. We also inspected urinary tract infections as a tracer outcome; although a fraction of urinary tract infections are hospital-acquired, they are not yet subject to public reporting, and the primary means of preventing nosocomial urinary tract infections (e.g., urinary catheter avoidance) differ from the prevention strategies for *C. difficile* [@pmed.1001268-Dubberke1],[@pmed.1001268-Lo1].

Analyses were performed using STATA procedure XTGEE. Patient confidentiality was maintained via encrypted health card numbers using Institute for Clinical Evaluative Sciences protocols.

Results {#s3}
=======

Cross-Validation of *C. difficile* Rates in Public Reporting and Administrative Datasets {#s3a}
----------------------------------------------------------------------------------------

The total number of *C. difficile* cases publicly reported by each Ontario hospital between September 1, 2008, and March 31, 2010, was compared to the corresponding number of cases recorded in the provincial administrative datasets. There was an excellent concordance for overall *C. difficile* cases ([Figure 1A](#pmed-1001268-g001){ref-type="fig"}; weighted Pearson\'s correlation coefficient 0.92), and nosocomial *C. difficile* cases ([Figure 1B](#pmed-1001268-g001){ref-type="fig"}; weighted Pearson\'s correlation coefficient 0.91) across these institutions.

![Correlation of aggregate hospital *C. difficile* cases in administrative datasets and public reporting statistics.\
*C. difficile* cases in the administrative data are plotted against cases from the public reporting database, for the total public reporting period between September 1, 2008, and March 31, 2010. Each bubble represents a distinct institution (*n* = 165), and bubble sizes reflect hospital sizes (in patient-days). There was an excellent correlation for overall *C. difficile* cases (A) (weighted Pearson\'s correlation coefficient 0.92), and hospital-acquired *C. difficile* cases (B) (weighted Pearson\'s correlation coefficient 0.91).](pmed.1001268.g001){#pmed-1001268-g001}

*C. difficile* Rates in Ontario prior to the Introduction of Public Reporting {#s3b}
-----------------------------------------------------------------------------

There were a total of 6,068,777 acute care hospital admissions, and 39,221,113 hospital days at risk for *C. difficile* infection in the pre-intervention period between April 1, 2002, and August 31, 2008. During this time there were 33,634 cases of *C. difficile* infection, corresponding to a rate of 5.54 per 1,000 hospitalizations or 8.58 per 10,000 patient-days. Of these cases, 14,956 (44.5%) were recorded as post-admission complications, corresponding to a rate of 2.46 nosocomial cases per 1,000 hospitalizations or 3.81 per 10,000 patient-days.

Provincial monthly rates per 10,000 patient-days did not differ by sex (data not shown), but did increase markedly in older age groups: 4.86 infections per 10,000 patient-days for 1--18 y olds, 2.88 for 19--30, 3.31 for 31--40, 5.84 for 41--50, 6.97 for 51--60, 8.55 for 61--70, 10.84 for 71--80, 12.05 for 81--90, and 12.46 for \>90 y olds. *C. difficile* rates were highest in large community hospitals (8.97 per 10,000 patient-days), followed by academic teaching hospitals (8.01) and small community hospitals (7.88).

There was marked seasonal variation in *C. difficile* rates, with yearly peaks in winter months ([Figure 2](#pmed-1001268-g002){ref-type="fig"}). In addition, crude *C. difficile* rates increased over this pre-intervention period, from 7.01 per 10,000 patient-days in 2002, to 6.39 in 2003, 8.14 in 2004, 9.5 in 2005, 8.23 in 2006, and 10.79 in 2007. The overall burden of antibiotic use in Ontario (as measured by outpatient antibiotic prescriptions to elderly individuals) also exhibited seasonal peaks preceding *C. difficile* peaks, and increased over the pre-intervention period ([Figure 2](#pmed-1001268-g002){ref-type="fig"}). The yearly antibiotic consumption increased from 2,110,184 prescriptions in 2003, to 2,323,006 in 2008, and 2,426,138 in 2009. The final predictive model incorporated age, hospital type, calendar month, and burden of antibiotic use in current and 12 lagged months. In this model there was no statistically significant longitudinal time trend prior to public reporting (the increase in pre-intervention rates was predicted by the combination of other covariates).

![Longitudinal trends in *C. difficile* infection rates and antibiotic prescription rates in Ontario prior to the introduction of mandatory public reporting.\
Seasonal variations in overall *C. difficile* infection rates (black solid line) and post-admission *C. difficile* infection rates (black dashed line) per 10,000 patient-days appear to follow seasonal changes in the overall monthly population burden of antibiotic prescriptions measured by the number of prescriptions in the Ontario Drug Benefit database (grey dashed line).](pmed.1001268.g002){#pmed-1001268-g002}

Predictors of Monthly *C. difficile* Rates {#s3c}
------------------------------------------

As compared to the reference age group of 61--70 y olds, all younger age groups had a reduced incidence rate ratio of *C. difficile* infection, while all older age groups had an increased incidence ([Table 1](#pmed-1001268-t001){ref-type="table"}). Infection rates were lower in small community hospitals, as compared to academic teaching hospitals. Higher *C. difficile* monthly rates were associated with higher total outpatient elderly antibiotic prescriptions in Ontario in the preceding months, with time lags up to 9 mo ([Table 1](#pmed-1001268-t001){ref-type="table"}).

10.1371/journal.pmed.1001268.t001

###### Predictors of monthly hospital-specific *C. difficile* infection rates in a multivariate Poisson model of the period prior to public reporting.

![](pmed.1001268.t001){#pmed-1001268-t001-1}

  Predictor                                                Rate Ratio   95% Confidence Interval
  ------------------------------------------------------- ------------ -------------------------
  **Age group** [a](#nt101){ref-type="table-fn"}                       
  1--18 y old                                                 0.57            0.34--0.95
  19--30 y old                                                0.34            0.29--0.40
  31--40 y old                                                0.39            0.33--0.46
  41--50 y old                                                0.69            0.61--0.78
  51--60 y old                                                0.81            0.73--0.91
  71--80 y old                                                1.27            1.14--1.41
  81--90 y old                                                1.39            1.25--1.55
  \>90 y old                                                  1.43            1.25--1.63
  **Hospital type** [b](#nt102){ref-type="table-fn"}                   
  Large community                                             1.03            0.94--1.12
  Small community                                             0.83            0.71--0.96
  **Total elderly outpatient antibiotic prescriptions**                
  Current month                                               1.03            0.90--1.17
  1 mo prior                                                  1.43            1.26--1.61
  2 mo prior                                                  1.35            1.19--1.54
  3 mo prior                                                  1.22            1.08--1.39
  4 mo prior                                                  0.98            0.86--1.11
  5 mo prior                                                  1.15            1.00--1.31
  6 mo prior                                                  1.26            1.09--1.46
  7 mo prior                                                  1.20            1.03--1.40
  8 mo prior                                                  1.22            1.07--1.39
  9 mo prior                                                  1.35            1.16--1.57
  10 mo prior                                                 1.10            0.94--1.27
  11 mo prior                                                 1.11            0.98--1.27
  12 mo prior                                                 0.90            0.78--1.04
  **Calendar month** [c](#nt103){ref-type="table-fn"}                  
  January                                                     1.07            0.91--1.27
  February                                                    1.11            0.96--1.29
  March                                                       1.21            1.03--1.41
  April                                                       1.23            1.07--1.41
  May                                                         1.15            1.02--1.30
  June                                                        0.98            0.89--1.07
  August                                                      1.05            0.96--1.14
  September                                                   1.04            0.93--1.15
  October                                                     1.02            0.89--1.17
  November                                                    0.96            0.83--1.12
  December                                                    0.99            0.85--1.14

Compared to 61--70 y old reference age group.

Compared to academic teaching hospital reference group.

Compared to July as a reference standard.

*C. difficile* Rates in Ontario following the Introduction of Public Reporting {#s3d}
------------------------------------------------------------------------------

After the introduction of public reporting, there was a gradual decline in age-specific hospital rates of *C. difficile* colitis in Ontario ([Figure 3](#pmed-1001268-g003){ref-type="fig"}). The observed post-intervention rates diverged from predicted rates based on the pre-reporting-period trends: rates were forecasted to continue to rise during this period ([Figure 3](#pmed-1001268-g003){ref-type="fig"}). There were 8,787 cases of *C. difficile* in Ontario during the 19-mo post-intervention period, as compared to 11,392 predicted by the Poisson model. In 2009, the first full calendar year after public reporting was instituted, there were only 5,417 cases (8.92 per 10,000 patient-days) as compared to 7,327 predicted by the Poisson model (12.16 per 10,000 patient-days, 95% CI 11.35--13.04 cases per 10,000 patient-days) (*p*\<0.001). This corresponded to a 26.7% reduction in *C. difficile* cases (95% CI 21.4%--31.6%). Predicted rates were higher than observed rates across all facility types, including large community hospitals (12.9 versus 10.1 per 10,000 patient-days), small community hospitals (10.1 versus 5.4 per 10,000 patient-days), and acute teaching hospitals (11.1 versus 7.5 per 10,000 patient-days). Public reporting was associated with a projected 1,970 cases averted in the first calendar year after introduction (95% CI 1,476--2,500 cases) ([Table 2](#pmed-1001268-t002){ref-type="table"}). Findings were similar in a sensitivity analysis excluding two large hospitals with the greatest discordance between *C. difficile* rates in the publicly reported and administrative datasets (data not shown).

![Reduced rates of *C. difficile* infection associated with the introduction of public reporting.\
Observed monthly rates of *C. difficile* infection in Ontario (solid blue line) were generally increasing prior to the introduction of public reporting in September 2008 (identified by black dotted line), and declined after this intervention. Post-intervention rates were significantly lower than rates predicted by a Poisson model (red dashed line) derived from pre-intervention data points and adjusted for age and hospital strata, and overall burden of community antibiotic use (with 0- to 12-mo lags).](pmed.1001268.g003){#pmed-1001268-g003}

10.1371/journal.pmed.1001268.t002

###### Cases of *C. difficile* averted by public reporting based on differences in observed and expected monthly case counts.

![](pmed.1001268.t002){#pmed-1001268-t002-2}

  Post-Intervention Month           Rate Ratio[a](#nt104){ref-type="table-fn"} (95% CI)   Number of Person-Days   Number of Expected Cases of *C. difficile* [b](#nt105){ref-type="table-fn"} (95% CI)   Number of Observed Cases of *C. Difficile*   Number of Averted Cases of *C. Difficile* (95% CI)
  -------------------------------- ----------------------------------------------------- ----------------------- -------------------------------------------------------------------------------------- -------------------------------------------- ----------------------------------------------------
  Sep 2008                                           1.07 (0.95--1.21)                           487,322                                             452 (401--510)                                                         485                                        −33 (−84 to 25)
  Oct 2008                                           1.10 (0.98--1.23)                           526,840                                             523 (467--590)                                                         576                                        −53 (−109 to 14)
  Nov 2008                                           0.99 (0.86--1.13)                           500,273                                             510 (447--585)                                                         506                                         4 (−59 to 79)
  Dec 2008                                           0.86 (0.76--0.96)                           513,768                                             579 (517--654)                                                         497                                          82 (20--157)
  Jan 2009                                           0.83 (0.74--0.94)                           534,666                                             603 (534--685)                                                         505                                          98 (29--180)
  Feb 2009                                           0.82 (0.73--0.92)                           493,535                                             562 (504--634)                                                         463                                          99 (41--171)
  Mar 2009                                           0.83 (0.73--0.93)                           534,744                                             674 (601--764)                                                         559                                         115 (42--205)
  Apr 2009                                           0.75 (0.66--0.84)                           511,188                                             665 (592--753)                                                         500                                         165 (92--253)
  May 2009                                           0.73 (0.64--0.82)                           505,739                                             615 (545--698)                                                         448                                         167 (97--250)
  Jun 2009                                           0.77 (0.69--0.87)                           516,594                                             609 (545--683)                                                         472                                         137 (73--211)
  Jul 2009                                           0.78 (0.69--0.87)                           508,844                                             624 (558--702)                                                         487                                         137 (71--215)
  Aug 2009                                           0.65 (0.57--0.74)                           466,992                                             559 (492--643)                                                         364                                         195 (128--279)
  Sep 2009                                           0.70 (0.62--0.80)                           480,041                                             536 (473--613)                                                         378                                         158 (95--235)
  Oct 2009                                           0.71 (0.62--0.81)                           515,581                                             568 (497--652)                                                         404                                         164 (93--248)
  Nov 2009                                           0.69 (0.60--0.79)                           503,973                                             622 (544--717)                                                         430                                         192 (114--287)
  Dec 2009                                           0.59 (0.51--0.68)                           501,327                                             689 (601--797)                                                         407                                         282 (194--390)
  Jan 2010                                           0.59 (0.51--0.68)                           516,159                                             669 (582--777)                                                         396                                         273 (186--381)
  Feb 2010                                           0.65 (0.57--0.75)                           485,781                                             610 (535--701)                                                         399                                         211 (136--302)
  Mar 2010                                           0.71 (0.62--0.81)                           540,613                                             721 (630--827)                                                         511                                         210 (119--316)
  Total post-intervention period                                                                                                                         11,392                                                            8,787                                            2,605

Relative risks for post-intervention months are observed over expected *C. difficile* counts, where expected count is based on the Poisson model predictions for that month.

Expected counts are based on Poisson model predictions for that month, adjusting for hospital, age strata, calendar month, and population antibiotic consumption with lags of 0--12 mo.

Tracer Outcomes Not Expected to Be Impacted by *C. difficile* Public Reporting {#s3e}
------------------------------------------------------------------------------

During the study period (April 1, 2002 to March 31, 2010) there were 6,545 hospital admissions for other leading bacterial gastrointestinal pathogens, corresponding to a rate of 0.87 per 1,000 hospital admissions, or 1.34 per 10,000 patient-days. The rate of these predominantly community-acquired infections did not change after the introduction of *C. difficile* public reporting ([Figure 4A](#pmed-1001268-g004){ref-type="fig"}).

![Tracer analyses evaluating longitudinal time trends of infections not expected to be impacted by hospital public reporting of *C. difficile* infection rates.\
Neither community-acquired bacterial gastrointestinal infections (A) nor urinary tract infections (B) exhibited a change in incidence concurrent with the introduction of *C. difficile* infection public reporting in September 2008.](pmed.1001268.g004){#pmed-1001268-g004}

There were 16,601 hospital admissions involving urinary tract infections, corresponding to a rate of 2.21 per 1,000 admissions, or 3.40 per 10,000 patient-days. Longitudinal trends in urinary tract infections did not change after the introduction of *C. difficile* public reporting ([Figure 4B](#pmed-1001268-g004){ref-type="fig"}).

Discussion {#s4}
==========

This longitudinal population-based cohort study has confirmed an immense burden of *C. difficile* infection in Ontario, while heralding mandatory hospital reporting as one potential means to reduce this burden. *C. difficile* infections affected more than 6,000 patients per year in Ontario, were more than twice as common as all other bacterial gastrointestinal and urinary tract infections combined, and increased over the 6.5-y pre-intervention period. However, with the introduction of public reporting in September 2008, *C. difficile* infections declined by 26% across Ontario, resulting in over 1,900 cases averted per year.

A number of jurisdictions in the United States, Canada, and the United Kingdom have introduced mandatory public reporting of hospital-acquired infections, including *C. difficile* colitis, and some have reported reductions in rates [@pmed.1001268-Ministre1],[@pmed.1001268-Health1]. However, our study represents the first attempt, to our knowledge, to measure population-based rates in a dataset that is independent from the public reporting system. In fact, a prior systematic review identified no rigorous studies investigating changes in health care--associated infection as an outcome of public reporting [@pmed.1001268-McKibben1]. Therefore, our findings provide important confirmation that public reporting can be associated with reductions in health care--associated infections on a broad scale.

Although we did not explore the mechanisms by which public reporting influenced *C. difficile* rates in this case, prior research suggests that the selection pathway (i.e., patients selecting higher performing institutions) is least likely to have impacted *C. difficile* rates in Ontario. A recent review suggests that the impact of public reports on consumers is related to the accessibility and ease of understanding the messages of the report [@pmed.1001268-Faber1]. However, in Ontario the reports are quite deeply buried on a MOHLTC website [@pmed.1001268-Ontario2]. So, even though the universal health care system in Ontario does not constrain individuals from choosing their own providers and institutions, it is unlikely that these reports led to shifts in patient selection of hospitals. It is more likely that public reporting elevated *C. difficile* to greater prominence on hospital quality improvement agendas, and motivated hospitals to adhere more closely to best practices in *C. difficile* prevention. Such practices, ranging from patient isolation to environmental cleaning, are well described in general infectious diseases society guidelines [@pmed.1001268-Dubberke1], and analogous Ontario guidelines were distributed to all hospitals. No financial incentives or disincentives were initially linked to *C. difficile* public reporting in Ontario, but hospitals may have anticipated that at some future point high rates could influence hospital reimbursement, akin to the US Centers for Medicare & Medicaid Services\' denial of hospital reimbursement for avoidable patient complications such as infection (termed "never events") [@pmed.1001268-Centers1]. In fact, subsequent legislation in Ontario has now mandated that executive compensation be linked to achieving quality improvement targets, including for *C. difficile* rates, starting in 2012 [@pmed.1001268-1].

This investigation confirmed prior findings that higher *C. difficile* rates are strongly associated with older patient age [@pmed.1001268-Kelly1],[@pmed.1001268-Miller1], large community hospitals [@pmed.1001268-Gilca1], and winter (respiratory virus) season [@pmed.1001268-Gilca1],[@pmed.1001268-Polgreen1]. Although prior antibiotic exposure is widely recognized as a cause of *C. difficile* colitis for individual patients (by disrupting normal intestinal flora) [@pmed.1001268-Kelly1],[@pmed.1001268-Poutanen1], we report a novel finding that population-level outpatient antimicrobial consumption is predictive of hospital *C. difficile* rates across a broad geographic region. Overall antibiotic prescription rates predicted *C. difficile* rates at lags of up to 9 mo. Seasonal increases in antibiotic use in winter appear to drive seasonal increases in *C. difficile* disease, and likely mediate the reported association between influenza and *C. difficile* seasonality [@pmed.1001268-Polgreen1]. Intriguingly, the apparent increases in *C. difficile* rates in Ontario between 2002 and 2008 are also potentially explained by corresponding increases in population antibiotic utilization. This finding provides strong support for the "antibiotic stewardship" movement, aimed at reducing unnecessary antibiotic use within institutional and community settings [@pmed.1001268-Dellit1].

Although study strengths include a population-based assessment of a system-level intervention with no loss to follow-up, as an observational study using health administrative data our study has some limitations. Our study findings may be influenced by misclassification of *C. difficile* outcome status in the administrative databases. However, the accuracy of these diagnostic codes are supported by patient-level validation studies in other jurisdictions [@pmed.1001268-Dubberke2],[@pmed.1001268-Scheurer1], as well as our own hospital-level cross-validation with Ontario public reporting statistics. Without a prospective, randomized trial we cannot be certain that *C. difficile* rates in Ontario were not influenced by some other temporal confounder, such as changes in *C. difficile* strain prevalence or antibiotic stewardship practices unrelated to *C. difficile* public reporting. However, the causal inference is strengthened by the duration of our longitudinal cohort (crude rates were rising for 6.5 y and then dropped coinciding with the intervention), the inclusion of crucial predictors of *C. difficile* (age and antibiotic utilization), and the assessment of control infectious diseases. Although public reporting could prompt some hospitals to underestimate the proportion of cases that were nosocomial, these hospitals are not likely to have underestimated the overall number of cases, since these figures were not subject to public reporting, and because ignoring cases or reducing laboratory testing of *C. difficile* could potentially lead to increased transmission of infection and more dramatic outbreaks. Nevertheless, given the potential for "gaming" of reported rates, and the potential for more thorough reporting in higher performing institutions, we utilized a data source for hospital *C. difficile* rates that was independent of the public reporting system itself.

This study provides to our knowledge the first population-based, rigorous evaluation of a public reporting system for hospital-acquired infection using an independent data source. In doing so, it provides support for ongoing public reporting of hospital *C. difficile* rates as a means of reducing the large population burden of this preventable disease. Future research will be required to discern the direct mechanism by which *C. difficile* infection rates are reduced in response to public reporting.
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